Cargando…
Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort
A hypercoagulable state has been described in coronavirus disease 2019 (COVID-19) patients. Others have reported a survival advantage with prophylactic anticoagulation (pAC) and therapeutic anticoagulation (tAC), but these retrospective analyses have important limitations such as confounding by indi...
Autores principales: | Ionescu, Filip, Grasso-Knight, Giovi, Castillo, Edward, Naeem, Ehsun, Petrescu, Ioana, Imam, Zaid, Patel, Vishal K., Narasimhan, Mangala, Nair, Girish B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519875/ https://www.ncbi.nlm.nih.gov/pubmed/32995704 http://dx.doi.org/10.1055/s-0040-1716721 |
Ejemplares similares
-
BIO-MECHANICS OF ARDS IN COVID-19: A PROSPECTIVE OBSERVATIONAL STUDY
por: Naeem, Ehsun, et al.
Publicado: (2020) -
Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients
por: Ionescu, Filip, et al.
Publicado: (2020) -
Extubation Failure in Critically Ill COVID-19 Patients: Risk Factors and Impact on In-Hospital Mortality
por: Ionescu, Filip, et al.
Publicado: (2021) -
Differential effects of ERK and p38 signaling in BMP-2 stimulated hypertrophy of cultured chick sternal chondrocytes
por: Reilly, Gwendolen C, et al.
Publicado: (2005) -
Gradient changes in bioprosthetic valve thrombosis: duration of anticoagulation and strategies to improve detection
por: Naser, Jwan A, et al.
Publicado: (2021)